DexTech Medical

10.00 SEK

+0.20 %

Less than 1K followers

DEX

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

+0.20 %
+4.17 %
-8.26 %
+9.29 %
+41.84 %
+85.19 %
+153.16 %
-77.25 %
+2.86 %

DexTech Medical operates in biotechnology. The company conducts research and development in the field of urological oncology, where common diseases include prostate cancer. A large part of the research is carried out in collaboration with other international players, research institutes and universities. The largest operations are found in the Nordic market. The company was founded in 2004 and is headquartered in Uppsala.

Read more
Market cap
184.86M SEK
Turnover
51.44K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
31/8
2026

Annual report '26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.